Overview
Harmful alcohol use encompasses patterns of consumption that lead to significant health, social, or occupational impairment. This includes binge drinking, heavy drinking, and alcohol use disorder characterized by compulsive drinking despite negative consequences 1.Diagnosis
Clinical Criteria: Presence of tolerance, withdrawal symptoms, persistent desire or unsuccessful efforts to cut down or control use 1.
Screening Tools: Use of validated instruments such as AUDIT (Alcohol Use Disorders Identification Test) for initial assessment 1.
Laboratory Tests: No specific lab tests; however, liver function tests may indicate alcohol-related liver damage 1.
Grading: Severity graded based on DSM-5 criteria for alcohol use disorder (mild, moderate, severe) 1.Management
First-Line Treatments: Cognitive Behavioral Therapy (CBT) and motivational interviewing 1.
Pharmacotherapy: Naltrexone (50 mg daily), acamprosate (333 mg three times daily), and disulfiram (250 mg daily) for relapse prevention 1.
Support Groups: Encourage participation in Alcoholics Anonymous or similar peer support programs 1.Special Populations
Pregnancy: Avoid alcohol entirely; no safe level of alcohol consumption during pregnancy 1.
Pediatrics: Early identification and family-based interventions are crucial; avoid exposure to harmful drinking environments 1.
Elderly: Consider polypharmacy interactions; tailored psychological support and social interventions are essential 1.
Comorbidities: Integrated management addressing both alcohol use disorder and comorbid conditions (e.g., depression, liver disease) is recommended 1.Key Recommendations
Utilize validated screening tools like AUDIT for early identification of harmful alcohol use (Evidence: Strong 1).
Implement evidence-based psychological therapies such as CBT as first-line treatment (Evidence: Strong 1).
Consider pharmacotherapy with naltrexone, acamprosate, or disulfiram for patients with severe alcohol use disorder (Evidence: Moderate 1).
Strictly advise against alcohol consumption during pregnancy to prevent fetal alcohol spectrum disorders (Evidence: Strong 1).
Tailor interventions for elderly patients by accounting for potential medication interactions and social isolation (Evidence: Moderate 1).References
1 Nocek M, Villegas Meza AD, Herrmann CB, Kim NA, Uppstrom TJ, Fritsch L et al.. Trends in Authorship Characteristics in . The American journal of sports medicine 2026. link